The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.

about

Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma].

P2860

Q32066576-A5C7D44A-7267-4F97-B374-C07B04A40D37 Q46720801-3DED3F00-6408-4C83-8456-977892BA3932

P2860

The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.

Item

http://www.wikidata.org/entity/Q48135531

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年学术文章

@wuu

1994年学术文章

@zh

1994年学术文章

@zh-cn

1994年学术文章

@zh-hans

1994年学术文章

@zh-my

1994年学术文章

@zh-sg

1994年學術文章

@yue

1994年學術文章

@zh-hant

name

The evaluation of hypothalamic ...... e in patients with acromegaly.

@en

The evaluation of hypothalamic ...... e in patients with acromegaly.

@nl

type

Item

label

The evaluation of hypothalamic ...... e in patients with acromegaly.

@en

The evaluation of hypothalamic ...... e in patients with acromegaly.

@nl

prefLabel

The evaluation of hypothalamic ...... e in patients with acromegaly.

@en

The evaluation of hypothalamic ...... e in patients with acromegaly.

@nl

P1476

The evaluation of hypothalamic ...... e in patients with acromegaly.

@en

P2093

A Sugawara

http://www.w3.org/2001/XMLSchema#string

A Utsumi

http://www.w3.org/2001/XMLSchema#string

H Ikeda

http://www.w3.org/2001/XMLSchema#string

K Abe

http://www.w3.org/2001/XMLSchema#string

K Hanew

http://www.w3.org/2001/XMLSchema#string

Y Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.

Pathophysiology of acromegaly.

Stimulation of adenosine 3',5'-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro.

Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.

Free intracellular Ca2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin.

Somatostatin inhibits growth hormone-releasing factor-stimulated adenylate cyclase activity in GH, cells.

A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

P2888

bf03348989

P304

313-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03348989

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1994-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7915736

http://www.w3.org/2001/XMLSchema#string

The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.

about

P2860

P2860

The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698